TY - JOUR
T1 - Dental implants in dentate primary and secondary Sjögren's syndrome patients
T2 - A multicenter prospective cohort study
AU - Maarse, Floor
AU - Fennis, Willem M.M.
AU - Twisk, Jos W.R.
AU - Korfage, Anke
AU - Santing, Hendrik J
AU - den Hartog, Laurens
AU - Muradin, Marvick S.M.
AU - Maningky, Melvin S
AU - Raghoebar, Gerry M.
AU - Vissink, Arjan
AU - Brand, Henk S.
AU - Jager, Derk Hendrik Jan
N1 - Funding Information: This study was funded by unconditional research grants from Foundation NutsOhra (FNO), Amsterdam, the Netherlands and Biohorizons Inc, Birmingham, AL, USA. No other conflicts of interest can be identified. We would like to thank all the participants of this study. We also like to thank Maxillofacial Dental Laboratory G. van Dijk, Groningen, the Netherlands, for fabricating the individualized X‐ray holders and superstructures. Publisher Copyright: © 2022 The Authors. Clinical Oral Implants Research published by John Wiley & Sons Ltd.
PY - 2022/11
Y1 - 2022/11
N2 - Objectives: To prospectively assess the clinical performance and patient-reported outcomes of dental implants in dentate patients with primary and secondary Sjögren's syndrome (pSS and sSS, respectively) compared to patients without SS. Materials and Methods: Thirty-seven implants were placed in 17 patients with pSS/sSS and 26 implants in 17 non-SS patients to replace missing (pre)molars. Clinical performance, marginal bone-level changes, patient satisfaction, and oral health-related quality of life (OHRQoL) were assessed at 1 (T1), 6 (T6), 12 (T12), and 18 (T18) months after placement of the superstructure. Marginal bone-level changes were measured on standardized dental radiographs. Clinical parameters included implant and crown survival, plaque, bleeding and gingival indices, and probing depth. Patient satisfaction and OHRQoL were assessed with validated questionnaires. Results: Implant survival at T18 was 100% in the patients with pSS/sSS and 96.2% in the non-SS group. Mean marginal bone loss at T18 did not differ between patients with pSS/sSS and non-SS patients, 1.10 ± 1.04 and 1.04 ± 0.75 mm, respectively (p =.87). Clinical performance was good with no differences between the groups for all outcome measures (p >.05). OHRQoL in patients with pSS/sSS had improved significantly after placement of implant supported crowns at all measuring moments compared to baseline (p <.05). Nevertheless, patient satisfaction and OHRQoL remained significantly higher for patients without SS at all measuring moments (p <.05). Conclusion: Dental implants can be successfully applied in dentate patients with pSS/sSS and have a positive effect on OHRQoL.
AB - Objectives: To prospectively assess the clinical performance and patient-reported outcomes of dental implants in dentate patients with primary and secondary Sjögren's syndrome (pSS and sSS, respectively) compared to patients without SS. Materials and Methods: Thirty-seven implants were placed in 17 patients with pSS/sSS and 26 implants in 17 non-SS patients to replace missing (pre)molars. Clinical performance, marginal bone-level changes, patient satisfaction, and oral health-related quality of life (OHRQoL) were assessed at 1 (T1), 6 (T6), 12 (T12), and 18 (T18) months after placement of the superstructure. Marginal bone-level changes were measured on standardized dental radiographs. Clinical parameters included implant and crown survival, plaque, bleeding and gingival indices, and probing depth. Patient satisfaction and OHRQoL were assessed with validated questionnaires. Results: Implant survival at T18 was 100% in the patients with pSS/sSS and 96.2% in the non-SS group. Mean marginal bone loss at T18 did not differ between patients with pSS/sSS and non-SS patients, 1.10 ± 1.04 and 1.04 ± 0.75 mm, respectively (p =.87). Clinical performance was good with no differences between the groups for all outcome measures (p >.05). OHRQoL in patients with pSS/sSS had improved significantly after placement of implant supported crowns at all measuring moments compared to baseline (p <.05). Nevertheless, patient satisfaction and OHRQoL remained significantly higher for patients without SS at all measuring moments (p <.05). Conclusion: Dental implants can be successfully applied in dentate patients with pSS/sSS and have a positive effect on OHRQoL.
KW - Sjögren's syndrome
KW - dental implants
KW - prosthodontics
KW - xerostomia
UR - http://www.scopus.com/inward/record.url?scp=85139443765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139443765&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/clr.13998
DO - https://doi.org/10.1111/clr.13998
M3 - Article
C2 - 36136091
SN - 0905-7161
VL - 33
SP - 1157
EP - 1170
JO - Clinical oral implants research
JF - Clinical oral implants research
IS - 11
ER -